Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients
- PMID:18240233
- DOI: 10.1002/art.23301
Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients
Abstract
Objective: To investigate whether central nervous system (CNS) stimulants used for the treatment of attention deficit hyperactivity disorder (ADHD) are associated with the development of Raynaud's syndrome (RS).
Methods: A case-control design was used for this study. All patients seen in a pediatric rheumatology practice during a 5-year period who had signs and symptoms of RS and met diagnostic criteria for RS as determined by pulse volume recording were studied as cases. Controls were randomly selected patients at the same clinic who did not have signs or symptoms of RS. They were matched to the cases for age, sex, and time of presentation. We tested for associations between various CNS medications and presence of RS. We also evaluated differences in laboratory test results between RS cases and matched controls.
Results: Sixty-four patients were enrolled in the study (32 cases with RS [23 female, 9 male] and 32 control patients). McNemar's test showed a significant association between the presence of RS and past or current use of ADHD stimulants (methylphenidate and dextroamphetamine) (chi(2) = 5.00, P = 0.01). The use of other CNS medications was not found to be significantly associated with RS (chi(2) = 1.33, P = 0.25 by McNemar's test). C-reactive protein levels and erythrocyte sedimentation rates were significantly higher in controls than in cases.
Conclusion: The results of this study indicate that there is a significant association between development of RS and therapy with CNS stimulants used for the treatment of ADHD. Although this was a small study, these findings provide preliminary evidence of an adverse effect of CNS stimulant medications in patients seen in rheumatology practice.
Similar articles
- Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.Syed RH, Moore TL.Syed RH, et al.J Clin Rheumatol. 2008 Feb;14(1):30-3. doi: 10.1097/RHU.0b013e3181639aaa.J Clin Rheumatol. 2008.PMID:18431096
- Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.Varley CK, Vincent J, Varley P, Calderon R.Varley CK, et al.Compr Psychiatry. 2001 May-Jun;42(3):228-33. doi: 10.1053/comp.2001.23145.Compr Psychiatry. 2001.PMID:11349243
- Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.Findling RL, et al.Clin Ther. 2009 Aug;31(8):1844-55. doi: 10.1016/j.clinthera.2009.08.002.Clin Ther. 2009.PMID:19808143Clinical Trial.
- An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.Chavez B, et al.Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26.Ann Pharmacother. 2009.PMID:19470858Review.
- Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.Findling RL.Findling RL.Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006.Clin Ther. 2008.PMID:18555941Review.
Cited by
- Blood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data.Hailpern SM, Egan BM, Lewis KD, Wagner C, Shattat GF, Al Qaoud DI, Shatat IF.Hailpern SM, et al.Front Pediatr. 2014 Sep 19;2:100. doi: 10.3389/fped.2014.00100. eCollection 2014.Front Pediatr. 2014.PMID:25285304Free PMC article.
- Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.Khouri C, Blaise S, Carpentier P, Villier C, Cracowski JL, Roustit M.Khouri C, et al.Br J Clin Pharmacol. 2016 Jul;82(1):6-16. doi: 10.1111/bcp.12912. Epub 2016 Apr 7.Br J Clin Pharmacol. 2016.PMID:26949933Free PMC article.Review.
- Digital Gangrene: An Unusual Manifestation of Non-Hodgkin Lymphoma.Momen Majumder MS, Ahmed S, Haque T, Haq SA, Chakravarty S, Shahin MA, Osmany DMF, Rasker JJ.Momen Majumder MS, et al.Case Rep Vasc Med. 2022 Mar 2;2022:8963753. doi: 10.1155/2022/8963753. eCollection 2022.Case Rep Vasc Med. 2022.PMID:35284148Free PMC article.
- Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies.Yasmeen F, Pirzada RH, Ahmad B, Choi B, Choi S.Yasmeen F, et al.Int J Mol Sci. 2024 Jul 12;25(14):7666. doi: 10.3390/ijms25147666.Int J Mol Sci. 2024.PMID:39062908Free PMC article.Review.
- Persistent Raynaud's Phenomenon Following Methylphenidate Hydrochloride Use During the COVID-19 Pandemic.Laboe C, Batchelder E, Vasireddy D.Laboe C, et al.Cureus. 2021 Sep 1;13(9):e17647. doi: 10.7759/cureus.17647. eCollection 2021 Sep.Cureus. 2021.PMID:34646694Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous